Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Peak Bio (PKBO) is now available.
Stephen LaMond has stepped down as the Interim CEO and COO of Peak Bio, Inc., and will transition to a consulting role to aid in handing over to new management. His departure is coupled with a separation agreement that includes a consulting fee and stock options, while Hoyoung Huh will take over CEO duties effective immediately. LaMond’s agreement includes financial compensation and benefits, ensuring a smooth management transition.
For an in-depth examination of PKBO stock, go to TipRanks’ Stock Analysis page.